Ocular Therapeutix pushes last round to $21M
Wed, 01/12/2011 - 3:37am
Ocular Therapeutix Inc., another eye therapy company launched by Amar Sawhney, has boosted its most recent funding round to $21 million, just days after Sawhney’s Eyegate Pharmaceuticals Inc. itself announced a funding bump.
Bedford-based Ocular is a developer of ophthalmic therapeutic products. According to a filing with the U.S. Securities and Exchange Commission, Ocular has upped its $15 million round filed in July 2009 by an additional $6 million.